Search

everythinglearnresearchcommunity

for

Search:↓

Early-onset male baldness is not linked to insulin resistance, but is significantly associated with metabolic syndrome.

Mesotherapy with stem cells showed promising hair growth results in some patients with hair loss, but more research is needed.

Topical 5α-reductase inhibitor helps counteract hair loss and stabilize it.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Afatinib often causes skin problems that need proactive management.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Enriching the French health care database with external data greatly improved its usefulness.

Platelet-rich plasma (PRP) was found not effective in treating male-patterned hair loss.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Spironolactone successfully treated hair loss in a 9-year-old girl.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.